VLG Insider Trading

Insider Ownership Percentage: 7.49%
Insider Buying (Last 12 Months): £58,290.40
Insider Selling (Last 12 Months): GBX 0

Venture Life Group Insider Trading History Chart

This chart shows the insider buying and selling history at Venture Life Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Venture Life Group Share Price & Price History

Current Price: GBX 42
Price Change: Price Increase of +1.5 (3.70%)
As of 04/24/2024 01:00 AM ET

This chart shows the closing price history over time for VLG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Venture Life Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/26/2023Carl DempseyInsiderBuy100,000GBX 38£38,000
5/25/2023Paul McGreevyInsiderBuy50,726GBX 40£20,290.40
4/5/2023Mark AdamsInsiderBuy23,412GBX 43£10,067.16
7/25/2022Paul McGreevyInsiderBuy42,866GBX 35£15,003.10
6/10/2022Paul McGreevyInsiderBuy138,571GBX 35£48,499.85
5/30/2022Paul McGreevyInsiderBuy148,868GBX 34£50,615.12
12/24/2021Jerry RandallInsiderBuy100,000GBX 30£30,000
12/3/2021Jerry RandallInsiderBuy100,000GBX 35£35,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Venture Life Group (LON:VLG)

52.87% of Venture Life Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Venture Life Group logo
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products; oncology products, including Gelclair, Pomi-T, and Xonrid that provides symptomatic relief for some of the side effects associated with cancer and its treatment; Earol and EarolSwim for the removal of ear wax, ensure ear hygiene and soothe, and prevent itchy and irritated ears; Sterinase supports nasal irrigation and hygiene; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products under the Balance Activ brand comprising BV treatment Gel and Pessaries; Intimate Daily Wash and Soothing Cream; Moisture Gel and Plus Pessaries; and Thrush Cream. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Read More on Venture Life Group

Today's Range

Now: GBX 42
Low: 40
High: 42.91

50 Day Range

MA: GBX 37.10
Low: 35
High: 40.50

52 Week Range

Now: GBX 42
Low: 27
High: 43.50

Volume

221,743 shs

Average Volume

182,975 shs

Market Capitalization

£53.13 million

P/E Ratio

N/A

Dividend Yield

0.09%

Beta

0.27

Who are the company insiders with the largest holdings of Venture Life Group?

Venture Life Group's top insider investors include:
  1. Carl Dempsey (Insider)
  2. Mark Adams (Insider)
  3. Paul McGreevy (Insider)
Learn More about top insider investors at Venture Life Group.